Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22137068 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Conditions: Cardiovascular Diseases;   Heart Diseases;   Heart Failure, Congestive
Interventions: Drug: Spironolactone (an aldosterone antagonist);   Drug: Placebo

Indicates status has not been verified in more than two years